Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001179110-21-009815)

Filing Details

Accession Number:: 0001179110-21-009815
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-11-03 16:02:09
Reporting Period:: 2021-11-01

Accepted Time:: 2021-11-03 16:02:09
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
744218	Celldex Therapeutics Inc.	CLDX	In Vitro & In Vivo Diagnostic Substances (2835)	133191702

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1718112	Margo Heath-Chiozzi	C/O Celldex Therapeutics, Inc. 53 Frontage Road, Suite 220 Hampton NJ 08827	Svp Of Regulatory Affairs	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-11-01	600	$2.78	11,847	No	4	M	Direct
Common Stock	Disposition	2021-11-01	600	$41.71	11,247	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Incentive Stock Option (Right to Buy)	Disposition	2021-11-01	600	$0.00	600	$2.78

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
42,400		2029-06-19	No	4	M	Direct

Footnotes

The sale of the shares of Common Stock were made pursuant to a plan intended to comply with Rule 10b5-1 of the Exchange Act, previously entered into on August 13, 2021.
25 % vested on June 19, 2020 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters.